Delta Capital Management’s Pfizer PFE Stock Holding History

Delta Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,474	Closed	-$1.56M	–	67
2020 Q1	$1.56M	Buy	50,474 +33,654	+200%	+$1.15M	1.27%	41
2019 Q4	$625K	Buy	+16,820	New	+$599K	0.39%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Delta Capital Management's PFE Position: Q2 2020 in Review

Delta Capital Management sold out of Pfizer (PFE) in Q2 2020, closing a stake of 50,474 shares — an estimated $1.56M sold.

Delta Capital Management first reported a position in PFE in Q4 2019 and held it in 2 quarters. The position peaked at $1.56M in Q1 2020. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Delta Capital Management reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
Delta Capital Management sold 50,474 Pfizer shares in Q2 2020, an estimated $1.56M.
Delta Capital Management first reported a position in Pfizer in Q4 2019 and held it in 2 quarters.
Delta Capital Management's Pfizer position peaked at $1.56M in Q1 2020.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Delta Capital Management's 13F filing for Q2 2020, filed 10 Aug 2020.